Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Large-scale testing (Phase 3)Study completedNCT03783442
What this trial is testing

Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 649
Testing effectiveness (Phase 2)Study completedNCT00507767
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06797986
What this trial is testing

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)HPV (Human Papillomavirus)-Associated CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Cellid Co., Ltd. 37
Testing effectiveness (Phase 2)Study completedNCT00002922
What this trial is testing

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01836029
What this trial is testing

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Celgene 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT01468896
What this trial is testing

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Ended earlyNCT00805012
What this trial is testing

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Seoul National University Hospital 96
Testing effectiveness (Phase 2)Study completedNCT02207530
What this trial is testing

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 112
Testing effectiveness (Phase 2)Study completedNCT00514943
What this trial is testing

BIBW 2992 (Afatinib) in Head & Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Boehringer Ingelheim 124
Testing effectiveness (Phase 2)Study completedNCT02499328
What this trial is testing

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

Who this might be right for
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 340
Large-scale testing (Phase 3)Active Not RecruitingNCT06082167
What this trial is testing

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Exelixis 600
Testing effectiveness (Phase 2)UnknownNCT03713372
What this trial is testing

Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Sinocelltech Ltd. 40
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03830385
What this trial is testing

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Sun Yat-sen University 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06719479
What this trial is testing

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

Who this might be right for
NPCHNSCCRecurrence+1 more
SUNHO（China）BioPharmaceutical CO., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT02052960
What this trial is testing

CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Glycotope GmbH 240
Testing effectiveness (Phase 2)Study completedNCT01469546
What this trial is testing

Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Michigan Rogel Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT01333852
What this trial is testing

Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsSquamous Cell Carcinoma
Lucas Vieira dos Santos 45
Next Page